Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics, Gedeon Richter Plc, Budapest, Hungary Purpose: Cari...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Nakamura T (Author), Kubota T (Author), Iwakaji A (Author), Imada M (Author), Kapás M (Author), Morio Y (Author)
Format: Knjiga
Izdano: Dove Medical Press, 2016-01-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto